Document is current

Any future updates will be listed below

Intravesical gemcitabine versus anthracyclines for primary and first recurrent non-muscle-invasive bladder cancer: a single-center retrospective study over 10 years

Crossref DOI link: https://doi.org/10.1007/s11255-025-04413-5

Published Online: 2025-02-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark